← Eichor
Condition: Epigenetic Disorder Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Epigenetic Disorder

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immun
Phase 1/Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT06694454
Feasibility Study to Investigate Rectal Mucus in Aero-Digestive Tract Cancer.
Phase N/A · 1 location(s) · Origin Sciences · NCT05102110
Remission Factors in Anorexia Nervosa
Phase N/A · 1 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT04560517
DNA Methylation and Vascular Function
NA · 1 location(s) · University of Illinois at Chicago · NCT03527420
PRE-Pregnancy Weight Loss And the Reducing Effect on CHILDhood Overweight - Aarhus
NA · 1 location(s) · Ulla Kampmann Opstrup · NCT05798494
"Studying The Role of Key Epigenetic Mediators in Breast Cancer Patients"
Phase N/A · 1 location(s) · Ain Shams University · NCT06759714
Colon Cancer Liquid Biopsy Investigation of Methylation-based Biomarkers Evaluation Using Delta-HLD (CLIMBED)
Phase N/A · 1 location(s) · Epiliquid Holding, Inc · NCT07168876
Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT01005654
Novel Epigenetic Mapping in Cell-Free DNA for the Detection of Lung Cancer
Phase N/A · 1 location(s) · JaxBio Ltd · NCT06963307
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
Phase 1 · 8 location(s) · Olema Pharmaceuticals, Inc. · NCT06784193
Allopregnanolone and Dynamic GABA-A Receptor Plasticity in Selective Serotonin Reuptake Inhibitor Responsive Premenstrua
Phase 4 · 2 location(s) · Johns Hopkins University · NCT06704594
Chidamide in Combination With Azacitidine, Liposomal Mitoxantrone, and Prednisone (CAMP Regimen) for the Treatment of Pr
Phase 2 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT05958719
A Prospective Randomised Study of Treatment Selection Based on Epigenetic Markers Versus Standard of Care Treatment Sele
NA · 39 location(s) · Alimentiv Inc. · NCT07363044
Colorectal Analysis for Signature Cancer Assessment Using Delta-HLD
Phase N/A · 1 location(s) · Epiliquid Holding, Inc · NCT07148297
Self-harm Behaviour Among the Most At-risk Adolescents
Phase N/A · 2 location(s) · University of Ljubljana, Faculty of Medicine · NCT05765864
ValproIc Acid to Potentiate Anti-EGFR Treatment Efficacy and Prevent/Revert Resistance in Colorectal Cancer
Phase 2 · 8 location(s) · National Cancer Institute, Naples · NCT06714357
To Conduct Multi-omics Integrated Studies in Peripheral Blood, Such as Fragment Omics, Metabolomics and Epigenetics, and
Phase N/A · 1 location(s) · Peking University People's Hospital · NCT07291921
Identifying Predictors Of Response To Mepolizumab In CRSwNP
Phase 4 · 1 location(s) · Centre hospitalier de l'Université de Montréal (CHUM) · NCT05902325
cfDNA 5mC/5hmC Biomarkers to Predict Chemotherapy Response in Metastatic Colorectal Cancer
Phase N/A · 1 location(s) · City of Hope Medical Center · NCT07224815
Decoding Epigenetic Mechanisms Driving Immune Evasion in Liver Cancer With Omics Approaches
Phase N/A · 1 location(s) · Niguarda Hospital · NCT07432347
ICU Biobank: Understanding Post-Intensive Care Syndrome (PICS)
Phase N/A · 1 location(s) · Medical University of Vienna · NCT06671795
Pesticides and Infertility: Oxidative Stress Via Circulating Cell-free DNA and Gut/Genital Microbiome Signatures in Wome
NA · 1 location(s) · Centre Hospitalier Universitaire, Amiens · NCT07471373
A Study of STX-1150 in Participants With Elevated Low-Density Lipoprotein Cholesterol (LDL-C)
Phase 1 · 2 location(s) · Monash University · NCT07428473
Viral Mucosal Reprogramming
Phase 2 · 1 location(s) · The University of Texas Medical Branch, Galveston · NCT05331170
Innate Immunity in COPD
Phase N/A · 2 location(s) · University of Edinburgh · NCT05743582
Personalized Patient Derived Xenograft (pPDX) Modeling to Test Drug Response in Matching Host
Phase N/A · 1 location(s) · University Health Network, Toronto · NCT02732860
Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapul
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT02146170
Discovering New Targets for Colorectal and Endometrial Cancer Risk Reduction
Phase N/A · 1 location(s) · Weill Medical College of Cornell University · NCT06096688
Genotype/Phenotype Correlation of MORC2 Mutations
Phase N/A · 12 location(s) · Hospices Civils de Lyon · NCT07038239
Target of Suv420h1/2 in Hepatocytes
NA · 1 location(s) · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · NCT06332677
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.